Drug-labels.com

Ratio-Clarithromycin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
250 mg, 500 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ratio-Clarithromycin

What the medication is used for:

ratio-CLARITHROMYCIN is used to treat certain infections caused by bacteria, such as pneumonia, bronchitis, infections of the sinuses, skin, and throat.

When used with other medications, it can treat infection caused by a bacteria called H. pylori. and reduce the risk of duodenal ulcer recurrence. A duodenal ulcer is a sore on the lining of the duodenum, which is the beginning of the small intestine.

It can also be prescribed to prevent and combat MAC disease in patients with HIV. MAC is a short word for Mycobacterium avium complex, the germs that cause MAC disease.

What it does:

ratio-CLARITHROMYCIN is an antibiotic that kills bacteria in your body.

When it should not be used:

Do not take ratio-CLARITHROMYCIN if you have ever had an allergic reaction to it, or if you are sensitive to it or erythromycin, or other antibacterial agents of the same family or to any ingredient in the formulation (see What the important nonmedicinal ingredients are:).

Do not take ratio-CLARITHROMYCIN if you are taking astemizole*, cisapride*, pimozide, terfenadine*, ergotamine, or dihydroergotamine. These medicines can interact, possibly leading to a irregular heartbeat pattern; deaths have occurred.

* no longer marketed in Canada.

What the medicinal ingredient is:

The medicinal ingredient is clarithromycin

What the important non-medicinal ingredients are:

The non-medicinal ingredients are the following: croscarmellose sodium, magnesium stearate, povidone, pregelatinized starch, silicon dioxide, and vanillin hydroxypropyl methylcellulose, hydroxypropyl methylcellulose/hypromellose, polyethylene glycol, maltodextrin, microcrystalline cellulose.

What dosage forms it comes in:

Film-coated tablets, 250 mg and 500 mg

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

ratio-CLARITHROMYCIN should not be used in pregnancy unless advised by your doctor due to potential hazards to the fetus. Do not take ratio-CLARITHROMYCIN without first talking to your doctor if you are breast-feeding a baby.

Before taking ratio-CLARITHROMYCIN, tell your doctor if you have liver or kidney disease. You may not be able to take clarithromycin, or you may require a lower dose and special monitoring during therapy. Talk to your doctor if ratio-CLARITHROMYCIN gives you prolonged and severe diarrhea.

The development of antibiotic resistance has been seen in patients with HIV receiving clarithromycin. To avoid failure of the treatment with a potential for developing antimicrobial resistance and a risk of failure with subsequent therapy, you should follow closely the prescribed regimen.

BEFORE you use ratio-CLARITHROMYCIN talk to
your doctor or pharmacist:
  • about all health problems you have now or have had
in the past;
  • about all other medicines you are taking, including non-
prescription medicines, nutritional supplements, or herbal
products; ( see INTERACTIONS WITH THIS
MEDICATION)
  • if you have or develop severe diarrhea as this may be a sign
of a more serious condition;
  • if you have kidney problems;
  • if you have liver problems;
  • if you are taking astemizole, terfenadine, cisapride,
pimozide, ergotamine, dihydroergotamine, digoxin, or
colchicine.
  • if you have any unusual or allergic reaction (rash,
difficulty breathing) to clarithromycin or any of the

ABOUT THIS MEDICINE

Product Monograph - ratio-CLARITHROMYCIN Page 77 of 78

nonmedicinal ingredients in ratio-CLARITHROMYCIN (see What the important nonmedicinal ingredients are), other medicines, foods, dyes, or preservatives;

  • if you are pregnant, trying to get pregnant or are breast-feeding because clarithromycin has beend detected in human breast milk.

WHILE taking ratio-CLARITHROMYCIN, contact your doctor if:

  • You develop symptoms of myasthenia gravis or the

    symptoms of your existing myasthenia gravis worsen. These symptoms could include muscle weakness that gets worse with activity and gets better with rest, drooping eyelid, blurred or double vision, difficulty chewing and swallowing, or trouble breathing.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with ratio-CLARITHROMYCIN
include:
Alaprazolam, alfentanil, astemizole/terfenadine, atorvastatin,
aztazanavir, bromocriptine, carbamazepine, cilostazol,
cisapride/pimozide, colchicine, cyclosporine, digoxin,
disopyramide/quinidine, efavirenz, ergotamine/
dihydroergotamine, fluconazole, hexobarbital, itraconazole,
lansoprazole/omeprazole, lovastatin/simvastatin,
methylprednisolone, midazolam/triazolam, nevirapine,
phenytoin, rifabutin/rifampin, rifapentine*, ritonavir/
indinavir, saquinavir, sildenafil, tacrolimus, tadalafil,
theophylline, tolterodine, valproic acid, vardenafil,
verapamil, vinblastine, warfarin/acenocoumarol, zidovudine
and drugs metabolized by cytochrome P450 system.
*not marketed in Canada.
PROPER USE OF THIS MEDICINE

Usual Adult Dose:

ratio-CLARITHROMYCIN may be taken with or without meals.

Respiratory Tract or Skin Infections:

The usual dosage of ratio-CLARITHROMYCIN is 250 mg to 500 mg every 12 hours for 7 to 14 days.

Infections with H. Pylori:

Triple Therapy: ratio-CLARITHROMYCIN + Omeprazole +Amoxillin

The recommended dose is the following for 10 days:

  • ratio-CLARITHROMYCIN: 500 mg every 12 hours
  • Omeprazole: 20 mg once daily
  • Amoxicillin: 1 g every 12 hours
Double Therapy: ratio-CLARITHROMYCIN + Omeprazole
The recommended dose is the following for 14 days:
  • ratio-CLARITHROMYCIN: 500 mg every 8 hours
  • Omeprazole: 40 mg once daily
followed by 20 mg omeprazole once daily for 14 days

MAC disease:

The recommended dose of ratio-CLARITHROMYCIN for prevention and treatment of MAC disease is 500 mg every 12 hours.

Treatment of disseminated MAC infection (MAC infection spread through your whole body) in patients with HIV should continue for life if improvement of symptoms is observed.

Overdose:

Contact your doctor or pharmacist if you have taken more than the recommended dose. Symptoms of ratio-CLARITHROMYCIN overdose are abdominal pain, vomiting, nausea, and diarrhea.

Missed Dose:

If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. In that case, skip the missed dose and take the next one as directed. Do not take double or extra doses.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, ratio-CLARITHROMYCIN can cause side effects. The majority of side effects observed in clinical trials with ratio-CLARITHROMYCIN were of a mild and transient nature.

The following adverse reactions were reported during the clinical studies with clarithromycin, the medicinal ingredient (occuring between 1% and 10% in clinical trials) or during post-marketing surveillance: abdominal pain, abnormal taste, diarrhea, ear disorder, flatulence, indigestion, headache, nausea, rash, vomiting. Talk to your doctor or pharmacist if any of these side effects persist or become bothersome.

Serious side effects from ratio-CLARITHROMYCIN are not common.

Product Monograph - ratio-CLARITHROMYCIN Page 78 of 78

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacist

Stop

taking drug and call your doctor or pharmacist

Only if severeIn all cases
UncommonAllergic
reactions*
Severe
diarrhea
Severe
abdominal
cramps

Irregular heart beat

T

T

T

T

* Allergic reactions, with symptoms such as itching, skin eruptions, rash, sore throat, fever, swelling, skin rash, itchiness, difficulty breathing, lightheadedness/dizziness.

This is not a complete list of side effects. For any unexpected effects while taking ratio- CLARITHROMYCIN, contact your doctor or pharmacist.

HOW TO STORE IT

Keep ratio-CLARITHROMYCIN and all medicines out of the reach of children.

Store at room temperature (15° - 25°C) in a tightly closed container. Protect from light. Do not use beyond expiry date.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, ratiopharm inc., at: 1-800-337-2584

Last revised: February 8, 2010.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

Report online at www.healthcanada.gc.ca/medeffect Call toll-free: 1-866-234-2345

Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701C

    Ottawa ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at

wwww.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of the side effect, contact your health professional. The Canada Vigiliance Program does not provide medical advice.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02247818

Revision date stated in the text: February 8, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ratio-Clarithromycin

Rx or OTC
Prescription (Rx)?
DIN 02247818, 02247819
Schedule(s) PRESCRIPTION
Active ingredient(s) Clarithromycin
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01F Macrolides, lincosamides and streptogramins
        1. J01FA Macrolides
          1. J01FA09 Clarithromycin
Company RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Current status Cancelled Post Market
Current status date September 19, 2014
Strengths and forms
DIN Strength Dosage form(s) Current status
02247818 250 MG Tablet Cancelled Post Market September 19, 2014
02247819 500 MG Tablet Cancelled Post Market September 19, 2014

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.